Sam is a trader and one of our lead stock analysts at AskTraders. After starting his career predominantly in the forex markets, Sam now focuses on gold and stocks with a preference for macroeconomic analysis.
Diversified holding company Digirad Corporation (NASDAQ: DRAD) has confirmed it will sell DMS health for $18.75 million.
The California-based company said that it has agreed to a stock purchase agreement with the proceeds being used to pay down its debt and finance its growth strategy.
Digirad transformed into a diversified holding company through its acquisition of ATRM Holdings in October 2019.
DMS Health is the mobile healthcare business unit of Digirad’s healthcare division and provides contract diagnostic imaging and healthcare expertise via a mobile service. The company generated a revenue of $41.3 million in 2019.
“The divestiture of DMS Health will allow us to streamline our portfolio of healthcare services by focusing our efforts on selling and servicing our Digirad branded solid-state imaging cameras and providing on-site imaging services to hospitals and physicians all over the country,” commented Matt Molchan, Dad’s CEO.
Shares of Digirad have surged premarket on Wednesday, up 25.05% at $3.17 after closing Tuesday’s session at $2.53.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .